Results 161 to 170 of about 458 (212)
Abstract Purpose To develop THESS‐ROP, a novel prediction model for treatment‐warranted retinopathy of prematurity (TW‐ROP) and compare its performance with four established models in a Greek cohort of consecutively screened preterm infants. Methods This ambispective cohort study included all 526 infants screened for ROP (2016–2022) at the 2nd ...
Stella Moutzouri +6 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
pH Stability of ophthalmic solutions
Optometry - Journal of the American Optometric Association, 2004In this study, we evaluated the pH value of 17 ophthalmic solutions, and we investigated whether the pH of these solutions changed over time after the bottle was opened.Fifteen bottles of each type of solution were chosen at random from different production lots. A 0.05-ml increment was taken from each bottle and was measured daily using a micropH 2002
Antonio López-Alemany, MIGUEL F Refojo
exaly +3 more sources
Optometry and Vision Science, 1974
ABSTRACT The relative viscosities of five agents commonly used in ophthalmic solutions as “viscosity builders” were measured as a function of their concentration.
R M, Hill, J E, Terry
openaire +2 more sources
ABSTRACT The relative viscosities of five agents commonly used in ophthalmic solutions as “viscosity builders” were measured as a function of their concentration.
R M, Hill, J E, Terry
openaire +2 more sources
Stability of tacrolimus ophthalmic solution
American Journal of Health-System Pharmacy, 2017The stability of 0.3-mg/mL tacrolimus ophthalmic solution at different storage temperatures was studied.A sterile ophthalmic solution of 0.3 mg/mL tacrolimus was prepared in triplicate under aseptic conditions by diluting tacrolimus in eye drops. Three aliquots of this solution were transferred into polypropylene bottles and stored at 25, 2-8, or -15 ...
Ezquer-Garin C +2 more
openaire +3 more sources
Stability of Pilocarpine Ophthalmic Solutions
Drug Development and Industrial Pharmacy, 1999The stability of pilocarpine and pilocarpine-timolol eyedrop preparations available on the Argentine market was studied. A high-performance liquid chromatographic method that allows the estimation of pilocarpine in the presence of degradation products was used for the study according to the preestablished design. It was found that pilocarpine solutions
C, Pilatti +3 more
openaire +2 more sources
European Journal of Ophthalmology, 1995
The efficacy and safety of ciprofloxacin (0.3%) ophthalmic solution and rifamycin (1%) ophthalmic solution for the treatment of bacterial conjunctivitis and blepharitis was compared in this randomized, double-masked, parallel-group study. Forty-one patients, 19 on ciprofloxacin and 22 on rifamycin, were culture-positive on admission and evaluated for ...
J P, Adenis +4 more
openaire +2 more sources
The efficacy and safety of ciprofloxacin (0.3%) ophthalmic solution and rifamycin (1%) ophthalmic solution for the treatment of bacterial conjunctivitis and blepharitis was compared in this randomized, double-masked, parallel-group study. Forty-one patients, 19 on ciprofloxacin and 22 on rifamycin, were culture-positive on admission and evaluated for ...
J P, Adenis +4 more
openaire +2 more sources
STABILITY OF PENICILLIN IN OPHTHALMIC SOLUTIONS
Archives of Ophthalmology, 1947IN THE past year several reports have been made concerning the stability of penicillin in solution or in ointment mixture. Gots and Glazer 1 found that specimens of solution and ointment containing 1,000 units per cubic centimeter remain active for approximately one month at room temperature. Kirby 2 found "considerable activity" in an istonic solution
openaire +2 more sources
Ketorolac 0.45% Ophthalmic Solution
Drugs & Aging, 2011Ketorolac 0.45% ophthalmic solution is a topical NSAID indicated in the US for the treatment of ocular pain and inflammation following cataract surgery. In animal studies, the ocular relative bioavailability of single-dose topical ketorolac 0.45% ophthalmic solution was 2- to 3-fold higher than that of ketorolac 0.4% ophthalmic solution.
openaire +2 more sources
Journal of the American Pharmaceutical Association (1961), 1961
Kurt Kleinmann, C. Lee Huyck
openaire +2 more sources
Kurt Kleinmann, C. Lee Huyck
openaire +2 more sources

